tiprankstipranks
Blurbs

Analysts Are Neutral on These Healthcare Stocks: Artivion (AORT), Arvinas Holding Company (ARVN)

Analysts fell to the sidelines weighing in on Artivion (AORTResearch Report) and Arvinas Holding Company (ARVNResearch Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Artivion (AORT)

Morgan Stanley analyst Cecilia Furlong maintained a Hold rating on Artivion today and set a price target of $16.00. The company’s shares closed last Friday at $13.31, close to its 52-week low of $12.90.

According to TipRanks.com, Furlong is a 4-star analyst with an average return of 15.3% and a 40.3% success rate. Furlong covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Zimmer Biomet Holdings, and Edwards Lifesciences.

Currently, the analyst consensus on Artivion is a Strong Buy with an average price target of $25.25.

See today’s best-performing stocks on TipRanks >>

Arvinas Holding Company (ARVN)

In a report released today, Akash Tewari from Jefferies maintained a Hold rating on Arvinas Holding Company, with a price target of $42.00. The company’s shares closed last Friday at $42.06, close to its 52-week low of $34.90.

According to TipRanks.com, Tewari is a 5-star analyst with an average return of 18.6% and a 47.8% success rate. Tewari covers the Healthcare sector, focusing on stocks such as Global Blood Therapeutics, Madrigal Pharmaceuticals, and BioMarin Pharmaceutical.

Currently, the analyst consensus on Arvinas Holding Company is a Strong Buy with an average price target of $84.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on AORT:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles